Glenmede Trust CO Na Organon & Co. Transaction History

Glenmede Trust CO Na

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$13.78 - $18.8 $14,262 - $19,458	-1,035 Reduced 2.55%	39,475 $742,000
Q4 2023 Feb 13, 2024	SELL	$10.95 - $17.32 $190,584 - $301,454	-17,405 Reduced 30.05%	40,510 $584,000
Q3 2023 Nov 14, 2023	BUY	$16.59 - $23.77 $721,150 - $1.03 Million	43,469 Added 300.91%	57,915 $1.01 Million
Q1 2023 May 15, 2023	SELL	$21.42 - $32.08 $5,076 - $7,602	-237 Reduced 1.61%	14,446 $339,000
Q4 2022 Feb 14, 2023	SELL	$23.31 - $28.61 $71,608 - $87,889	-3,072 Reduced 17.3%	14,683 $410,000
Q3 2022 Nov 16, 2022	SELL	$23.4 - $34.25 $55,387 - $81,069	-2,367 Reduced 11.76%	17,755 $415,000
Q2 2022 Aug 15, 2022	SELL	$31.66 - $38.9 $500,322 - $614,736	-15,803 Reduced 43.99%	20,122 $678,000
Q1 2022 May 16, 2022	SELL	$30.45 - $39.36 $906,892 - $1.17 Million	-29,783 Reduced 45.33%	35,925 $1.25 Million
Q4 2021 Feb 15, 2022	SELL	$28.67 - $37.13 $265,770 - $344,195	-9,270 Reduced 12.36%	65,708 $2 Million
Q3 2021 Nov 15, 2021	SELL	$28.63 - $35.64 $75,611 - $94,125	-2,641 Reduced 3.4%	74,978 $2.46 Million
Q2 2021 Aug 16, 2021	BUY	$28.45 - $38.0 $2.21 Million - $2.95 Million	77,619 New	77,619 $2.35 Million

809

207M

1.19M

910K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.89B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

Stay updated on Glenmede Trust CO Na with notifications on news.